Chen, Y., Yuan, X., Yan, W., Zou, Y., Wei, H., Wei, Y., . . . Chen, L. (2025). CMD-OPT model enables the discovery of a potent and selective RIPK2 inhibitor as preclinical candidate for the treatment of acute liver injury. Elsevier.
Chicago Style (17th ed.) CitationChen, Yong, et al. CMD-OPT Model Enables the Discovery of a Potent and Selective RIPK2 Inhibitor as Preclinical Candidate for the Treatment of Acute Liver Injury. Elsevier, 2025.
MLA (9th ed.) CitationChen, Yong, et al. CMD-OPT Model Enables the Discovery of a Potent and Selective RIPK2 Inhibitor as Preclinical Candidate for the Treatment of Acute Liver Injury. Elsevier, 2025.
Warning: These citations may not always be 100% accurate.